7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
Meet Veristat at BIOCHINA & CMAC: Advancing Global Clinical Development
🔬 Connecting with the Global Biotech Community
We are pleased to be attending BIOCHINA, where innovators from across the biotech ecosystem come together to discuss the future of drug development and global regulatory strategy. As more companies pursue international pathways for approval, thoughtful clinical planning and strong data strategies have never been more important. Our team looks forward to engaging with fellow leaders, sharing perspectives, and exploring how we can help advance complex therapies from development to regulatory success.
We are also looking forward to attending the CMAC Annual Meeting and spending time with colleagues across the clinical development ecosystem. It’s so valuable to step away from day-to-day program work and have thoughtful conversations about the evolving challenges in trial design, data strategy, and regulatory expectations. So we’re excited to exchange ideas, share perspectives from complex development programs, and connect with teams advancing the next generation of therapies.
👥 Meet the Veristat Team at BIOCHINA & CMAC
Connect with our experts to explore how Veristat’s tailored solutions can advance your clinical and regulatory milestones:
-
Lorenzo Scalise: Business Development Representative
-
Daphne Smyth: Vice President Regulatory
-
AJ Mills: Executive Vice President
📅 Schedule a meeting in advance
By completing the form on this page. We welcome the opportunity to discuss your upcoming programs and how Veristat can be a strategic partner in your success.
💡 Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
Let’s shape the future of clinical research—together.
Schedule A Meeting
Meet with us at BIOCHINA & CMAC in China March 12-20, 2026
3 min read
Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...